Update and Evaluation of a Preoperative Scoring System to Predict Long-Term Outcomes After Microvascular Decompression in Trigeminal Neuralgia

Operative Neurosurgery 29:824–831, 2025

This clinical research article evaluates and compares two preoperative scoring systems predicting long-term pain freedom after microvascular decompression (MVD) for trigeminal neuralgia (TN). Using a retrospective cohort of 410 patients with mean 63-month follow-up, the study tests the Panczykowski score (system A) and proposes a new four-variable Preoperative TN Scoring System (system B) incorporating age, TN type, neurovascular compression, and response to carbamazepine.

Results show both systems reliably stratify likelihood of pain freedom without medication, with higher scores predicting better outcomes; immediate and late complication rates are reported and limitations—including selection bias and evolving diagnostic criteria—are discussed, emphasizing need for broader external validation before widespread adoption.

Scoring Systems for Trigeminal Neuralgia (TN): Two preoperative scoring systems, the Panczykowski Score (A) and a new 4-variable Preoperative Trigeminal Neuralgia Scoring System (B), were evaluated for predicting long-term pain freedom after microvascular decompression (MVD) in TN patients.

Key Predictive Variables: Age over 45 years, classical TN type, positive response to carbamazepine, and presence/severity of neurovascular compression (NVC) significantly predict postoperative pain freedom without medication.

Scoring System A (Panczykowski): Utilizes three variables—TN type (classical/nonclassical), response to carbamazepine, and graded NVC—to assign a score from 1 to 5; higher scores correlate with greater likelihood of long-term pain freedom.

Scoring System B (Updated): Incorporates four variables—age (>45), TN type, response to carbamazepine, and NVC grade (with updated definitions)—assigning one point for each, for a total score of 0 to 4; higher scores predict increased chance of pain freedom.

Predictive Value: Both scoring systems reliably predict long-term pain freedom after MVD, with patients scoring higher on either system significantly more likely to be pain free without medication at long-term follow-up (up to 82% for highest scores).

Complication Rates: Immediate postoperative complication rate was 3.7% and late complication rate was 8.1%, with facial numbness, infection, and hearing loss among the most common complications.

Clinical Application and Limitations: These scoring systems can guide preoperative counseling and surgical candidate selection but may be limited by selection bias, changing TN diagnostic criteria, and potential oversimplification of complex patient profiles; external validation is needed before universal adoption.

Conclusion: Incorporating individual patient factors into preoperative scoring helps identify TN patients most likely to benefit from MVD, but further research and validation in broader populations are necessary for widespread clinical use.